| Identification | Back Directory | [Name]
Propanoic acid, 2,2-dimethyl-, 1,1′,1′′,1′′′-[[2-(2-thiazolylamino)ethylidene]bis[phosphinylidynebis(oxymethylene)]] ester | [CAS]
1950647-99-0 | [Synonyms]
Propanoic acid, 2,2-dimethyl-, 1,1′,1′′,1′′′-[[2-(2-thiazolylamino)ethylidene]bis[phosphinylidynebis(oxymethylene)]] ester | [Molecular Formula]
C29H50N2O14P2S | [MOL File]
1950647-99-0.mol | [Molecular Weight]
744.73 |
| Hazard Information | Back Directory | [Description]
HUN47990 is a bisphosphonate (BP) prodrug with antitumor activity. HUN47990 potently inhibits the in vitro growth of a variety of tumor cell lines, especially hematopoietic cell lines, at nanomolar concentrations. HUN47990 inhibited the prenylation of the RAP1A small GTPase signaling protein at concentrations as low as 1-10 nM. HUN47990 slowed the growth of human bladder cancer cells in an immunodeficient mouse model. HUN47990 is significantly more active than zoledronic acid, the most active FDA-approved BP, and a potential anti-cancer therapeutic. HUN47990 was first reported in ChemMedChem. 2016 Dec 16;11(24):2656-2663 (compound 7). This product has no formal name at the moment. |
|
|